ASBC 19.23 Associated Banc-Corp $ASBC Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ASBC 19.23 Associated Banc-Corp $ASBC Hit a 52 week high of 19.21 Closing the day 09:45 at 19.23 +0.08 +0.42% With a day low of 19.03 and a total volume of 38,563.

ASBC Recent Posts: http://investorshangout.com/Associated-Banc-Corp-ASBC-53383/

AMP Ameriprise Financial Services Recent Headline News

Shares of AMP Up 12.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Nov 11, 9:37AM CST
SmarTrend identified an Uptrend for Ameriprise Financial (NYSE:AMP) on October 22nd, 2014 at $115.65. In approximately 3 weeks, Ameriprise Financial has returned 12.72% as of today's recent price of $130.36.
AMP: 130.10 (-0.26)

Ameriprise Financial Earnings In Retrospect: Up 7.3% in the Last 13 Days (AMP)
Comtex SmarTrend(R) - Mon Nov 10, 9:59AM CST
13 days ago, on October 28th, 2014, Ameriprise Financial (NYSE:AMP) reported its earnings. Analysts, on average, expected earnings of $1.96 per share on sales of $3.1 billion. The company actually reported EPS of $2.10 on sales of $3.1 billion, beating EPS estimates by $0.14 and beating revenue estimates by $20.8 million. Since the company's report, shares of Ameriprise Financial have risen from $120.30 to $129.05, representing a gain of 7.3% in the past 13 days.
AMP: 130.10 (-0.26)

Invesco Challenged And Passed 1-Year High
Tyler Griffin - at Seeking Alpha - Sun Nov 09, 11:50PM CST

TROW: 82.92 (-0.25), IVZ: 40.87 (-0.18), AMP: 130.10 (-0.26)

Morning Briefing on Asset Management and Custody Banks Stocks - Apollo Global Management, Och-Ziff Capital Management, Apollo Investment, Ameriprise Financial, and BlackRock
PR Newswire - Thu Nov 06, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Apollo Global Management LLC (NYSE: APO), Och-Ziff Capital Management Group LLC (NYSE: OZM), Apollo Investment Corporation (NASDAQ: AINV), Ameriprise Financial Inc. (NYSE: AMP), and BlackRock Inc. (NYSE: BLK). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, November 05, 2014, mostly ended on a higher note as the Dow Jones Industrial Average finished at 17,484.53, up 0.58% and the NASDAQ Composite closed at 4,620.72, down 0.06%. The S&P 500 finished the session 0.57% higher at 2,023.57. During the trading session, nine out of ten sectors finished on a positive note. The S&P 500 Financials Sector Index ended the day at 324.54, up 0.63%, with the index advancing 8.68% in the previous three months. Register for your complimentary reports on these five stocks at:
APO: 22.80 (-0.72), BLK: 349.88 (-1.31), AINV: 8.23 (-0.05), AMP: 130.10 (-0.26), OZM: 11.19 (-0.31)

Ameriprise Financial Set to Possibly Pullback After Yesterday's Rally of 1.22%
Comtex SmarTrend(R) - Tue Nov 04, 5:35PM CST
Ameriprise Financial (NYSE:AMP) traded in a range yesterday that spanned from a low of $126.15 to a high of $128.00. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $127.39 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMP: 130.10 (-0.26)

After Yesterday's Rally of 1.22% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 04, 5:34PM CST
Ameriprise Financial (NYSE:AMP) traded in a range yesterday that spanned from a low of $126.15 to a high of $128.00. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $127.39 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMP: 130.10 (-0.26)

Why is Fortress Investment Up Despite Q3 Earnings Miss? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 12:00PM CST
Higher expenses dragged results of Fortress Investment Group LLC (FIG) and it consequently failed to deliver a positive earnings surprise
SEIC: 39.41 (-0.15), FIG: 7.32 (-0.01), BLK: 349.88 (-1.31), AMP: 130.10 (-0.26)

Apollo Global (APO) Q3 Earnings Miss on Lower Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:50AM CST
Dismal performance in the private equity segment dragged third-quarter 2014 results of Apollo Global Management, LLC (APO)
SEIC: 39.41 (-0.15), APO: 22.80 (-0.72), BLK: 349.88 (-1.31), AMP: 130.10 (-0.26)

Financial Performance, Study Results, and Asset Sale - Research Reports on Capital One, Chubb, Ameriprise, Simon and American Realty
PR Newswire - Thu Oct 30, 7:35AM CDT
Today, Analysts Review released its research reports regarding Capital One Financial Corp. (NYSE: COF), The Chubb Corporation (NYSE: CB), Ameriprise Financial, Inc. (NYSE: AMP), Simon Property Group Inc. (NYSE: SPG) and American Realty Capital Properties Inc. (NASDAQ: ARCP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7557-100free.
SPG: 179.23 (-1.38), COF: 81.62 (-0.56), AMP: 130.10 (-0.26), CB: 101.35 (-0.14), ARCP: 8.64 (-0.02)

After Yesterday's Rally of 2.88% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 29, 4:25PM CDT
Ameriprise Financial (NYSE:AMP) traded in a range yesterday that spanned from a low of $121.57 to a high of $126.12. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $120.47 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMP: 130.10 (-0.26)

Ameriprise Financial Rises 2.88% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Oct 29, 4:24PM CDT
Ameriprise Financial (NYSE:AMP) traded in a range yesterday that spanned from a low of $121.57 to a high of $126.12. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $120.47 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMP: 130.10 (-0.26)

Ameriprise Financial's (AMP) CEO Jim Cracchiolo on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 2:27PM CDT

AMP: 130.10 (-0.26)

Ameriprise Financial (AMP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Oct 29, 12:03PM CDT
The following Ameriprise Financial (AMP) conference call took place on October 29, 2014, 09:00 AM ET. This is a transcript of that earnings call:
AMP: 130.10 (-0.26)

Ameriprise's Q3 Earnings Beat on Revenue & AUM Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 9:40AM CDT
Ameriprise (AMP) reported third-quarter 2014 adjusted operating earnings per share of $2.24, outpacing the Zacks Consensus Estimate of $1.95. Moreover, the figure came in 28% above the year-ago quarter.
BX: 31.55 (-0.07), BLK: 349.88 (-1.31), TROW: 82.92 (-0.25), AMP: 130.10 (-0.26)

Ameriprise Financial announces dividend of USD0.58 per share for quarter
M2 - Wed Oct 29, 3:26AM CDT
The board of directors of Ameriprise Financial Inc (NYSE:AMP), a provider of financial products and services, authorised a quarterly cash dividend of USD0.58 per share on the company's common stock, it disclosed on Wednesday.
AMP: 130.10 (-0.26)

Ameriprise Financial declares $0.58 dividend
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:44PM CDT

AMP: 130.10 (-0.26)

Wealth management drives strong quarter for Ameriprise
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 3:54PM CDT

AMP: 130.10 (-0.26)

Ameriprise Financial beats by $0.14, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 3:11PM CDT

AMP: 130.10 (-0.26)

Ameriprise Financial Declares Regular Quarterly Dividend
Business Wire - Tue Oct 28, 3:07PM CDT
The Board of Directors of Ameriprise Financial, Inc. (NYSE: AMP) has declared a quarterly cash dividend of $0.58 per common share payable on November 21, 2014 to shareholders of record at the close of business on November 10, 2014.
AMP: 130.10 (-0.26)

Ameriprise Financial Reports Third Quarter 2014 Results
Business Wire - Tue Oct 28, 3:05PM CDT
--Operating EPS increased 10 percent to $2.10Excluding unlocking(2) in both quarters, operating EPS increased 28 percent to $2.24
AMP: 130.10 (-0.26)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading